DDInter948 DDInter366
Human interferon beta (165 residues), cysteine 17 is substituted with serine. Produced in E. coli, no carbohydrates, MW=18.5kD
A centrally acting central muscle relaxant with sedative properties. It is claimed to inhibit muscle spasm by exerting an effect primarily at the level of the spinal cord and subcortical areas of the brain. (From Martindale, The Extra Pharmacopoea, 30th ed, p1202)
Chlorzoxazone {u} (Compound) binds {v} (Gene) CYP2A6
Chlorzoxazone {u} (Compound) is included by {v} (Pharmacologic Class) Centrally-mediated Muscle Relaxation
Chlorzoxazone {u} (Compound) causes {v} (Side Effect) Dermatitis
Chlorzoxazone {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Naltrexone
Chlorzoxazone {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Clemastine
Chlorzoxazone {u} may lead to a major life threatening interaction when taken with {v} Morphine
Chlorzoxazone {u} may lead to a major life threatening interaction when taken with {v} Teriflunomide
Chlorzoxazone (Compound) binds CYP2A6 (Gene)
Chlorzoxazone (Compound) is included by Centrally-mediated Muscle Relaxation (Pharmacologic Class)
Chlorzoxazone (Compound) causes Dermatitis (Side Effect)
Chlorzoxazone may cause a moderate interaction that could exacerbate diseases when taken with Naltrexone
Chlorzoxazone may cause a moderate interaction that could exacerbate diseases when taken with Clemastine
Chlorzoxazone may lead to a major life threatening interaction when taken with Morphine
Chlorzoxazone may lead to a major life threatening interaction when taken with Teriflunomide